Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don J Diamond

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
The Journal of Infectious Diseases|March 6, 2020
The Status of Vaccine Development Against the Human CytomegalovirusStanley A Plotkin, Dai Wang, Abdel Oualim, et al.
Haematologica|March 1, 2024
Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antiviralsCorinna La Rosa, Yoonsuh Park, Dongyun Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challengePirouz Daftarian, Saima Ali, Rahul Sharan, et al.
Cancer Research|October 24, 2012
Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growthCéline A Blache, Edwin R Manuel, Teodora I Kaltcheva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2012
Intracerebral CpG immunotherapy with carbon nanotubes abrogates growth of subcutaneous melanomas in miceHaitao Fan, Ian Zhang, Xuebo Chen, et al.
Transplantation|September 28, 2002
Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplantsSimon F Lacey, Ghislaine Gallez-Hawkins, Matthew Crooks, et al.
Cancer Immunology Research|July 3, 2015
Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic TumorsEdwin R Manuel, Jeremy Chen, Massimo D'Apuzzo, et al.
Cancer Research Communications|November 30, 2023
Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian CancerFerdynand J Kos, Paul Frankel, Mihaela Cristea, et al.
Journal of Virology|September 18, 2015
Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast InfectionFlavia Chiuppesi, Felix Wussow, Erica Johnson, et al.
Journal of Virology|March 30, 2004
Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirusZhongde Wang, Corinna La Rosa, Rebecca Maas, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|March 6, 2020
The Status of Vaccine Development Against the Human CytomegalovirusStanley A Plotkin, Dai Wang, Abdel Oualim, et al.
Haematologica|March 1, 2024
Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antiviralsCorinna La Rosa, Yoonsuh Park, Dongyun Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challengePirouz Daftarian, Saima Ali, Rahul Sharan, et al.
Cancer Research|October 24, 2012
Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growthCéline A Blache, Edwin R Manuel, Teodora I Kaltcheva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2012
Intracerebral CpG immunotherapy with carbon nanotubes abrogates growth of subcutaneous melanomas in miceHaitao Fan, Ian Zhang, Xuebo Chen, et al.
Transplantation|September 28, 2002
Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplantsSimon F Lacey, Ghislaine Gallez-Hawkins, Matthew Crooks, et al.
Cancer Immunology Research|July 3, 2015
Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic TumorsEdwin R Manuel, Jeremy Chen, Massimo D'Apuzzo, et al.
Cancer Research Communications|November 30, 2023
Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian CancerFerdynand J Kos, Paul Frankel, Mihaela Cristea, et al.
Journal of Virology|September 18, 2015
Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast InfectionFlavia Chiuppesi, Felix Wussow, Erica Johnson, et al.
Journal of Virology|March 30, 2004
Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirusZhongde Wang, Corinna La Rosa, Rebecca Maas, et al.
Pageof 14